2 completed, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
Follow Hepatitis Resource Network: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
HIV Infections (2)
Ribavirin (3) · peginterferon alfa-2b (1)
United States (3)
Mark Sulkowski, MD (2) · Douglas Dieterich, MD (1)